Heartbeam Inc (BEAT)vsDoximity Inc (DOCS)
BEAT
Heartbeam Inc
$0.43
+5.16%
HEALTHCARE · Cap: $30.99M
DOCS
Doximity Inc
$32.87
+0.34%
HEALTHCARE · Cap: $6.10B
Smart Verdict
WallStSmart Research — data-driven comparison
DOCS leads profitability with a 25.5% profit margin vs 0.0%. DOCS earns a higher WallStSmart Score of 57/100 (C).
BEAT
Avoid18
out of 100
Grade: F
DOCS
Buy57
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for BEAT.
Margin of Safety
+49.3%
Fair Value
$51.22
Current Price
$32.87
$18.35 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 21 in profit
Keeps 26 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 21.5%
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 51.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : BEAT
The strongest argument for BEAT centers on Price/Book.
Bull Case : DOCS
The strongest argument for DOCS centers on Debt/Equity, Altman Z-Score, Return on Equity. Profitability is solid with margins at 25.5% and operating margin at 21.5%. PEG of 0.59 suggests the stock is reasonably priced for its growth.
Bear Case : BEAT
The primary concerns for BEAT are Revenue Growth, EPS Growth, Market Cap.
Bear Case : DOCS
The primary concerns for DOCS are Piotroski F-Score, P/E Ratio, EPS Growth. A P/E of 40.3x leaves little room for execution misses.
Key Dynamics to Monitor
BEAT profiles as a value stock while DOCS is a mature play — different risk/reward profiles.
DOCS carries more volatility with a beta of 1.22 — expect wider price swings.
DOCS is growing revenue faster at 7.3% — sustainability is the question.
DOCS generates stronger free cash flow (42M), providing more financial flexibility.
Bottom Line
DOCS scores higher overall (57/100 vs 18/100), backed by strong 25.5% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Heartbeam Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.
Visit Website →Doximity Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?